SAN FRANCISCO & SYDNEY--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tools, today announced a strategic collaborative agreement with GenesisCare, an integrated cancer care provider.

旧金山和悉尼--（商业新闻短讯）--基于多模式人工智能（MMAI）的预测和预后癌症工具的开发人员ArteraAI今天宣布与综合癌症护理提供商GenesisCare达成战略合作协议。

The agreement allows for ArteraAI and GenesisCare to collaborate in Australia to generate real-world data on AI tools guiding treatment decisions as part of a new clinical trial.

该协议允许ArteraAI和GenesisCare在澳大利亚进行合作，以生成有关AI工具的真实数据，指导治疗决策，作为新临床试验的一部分。

“We are honored to be able to partner with GenesisCare to provide the clinical community in Australia a way to personalize care for their patients,” said Andre Esteva, co-founder and CEO of ArteraAI.

ArteraAI联合创始人兼首席执行官安德烈·埃斯特瓦（Andre Esteva）表示：“我们很荣幸能够与GenesisCare合作，为澳大利亚的临床社区提供一种为患者提供个性化护理的方式。”。

ArteraAI and GenesisCare share a commitment to clinical innovation and advancing precision medicine, with the aim of improving the lives of patients with localized prostate cancer.

ArteraAI和GenesisCare共同致力于临床创新和推进精准医学，旨在改善局限性前列腺癌患者的生活。

“Our research partnership with ArteraAI aligns with our aim to offer personalized and patient-centric care in communities across Australia,” said Professor Jarad Martin, GenesisCare Radiation Oncologist.

GenesisCare放射肿瘤学家贾拉德·马丁（JaradMartin）教授表示：“我们与ArteraAI的研究伙伴关系符合我们在澳大利亚各地社区提供个性化和以患者为中心的护理的目标。”。

About ArteraAI

关于ArteraAI

ArteraAI is a leading precision medicine company developing AI tools to personalize cancer therapy.

ArteraAI是一家领先的精准医学公司，开发AI工具以个性化癌症治疗。

ArteraAI’s multimodal artificial intelligence (MMAI) biomarker tool leverages a unique algorithm that assesses digital images from a patient’s biopsy and learns from a patient's clinical data. The AI combines this information to predict whether a patient will benefit from a particular therapy and determine their prognosis..

ArteraAI的多模式人工智能（MMAI）生物标志物工具利用了一种独特的算法，可以评估患者活检的数字图像，并从患者的临床数据中学习。AI结合这些信息来预测患者是否会从特定疗法中受益并确定其预后。。

About GenesisCare Australia

关于GenesisCare Australia

GenesisCare is an integrated cancer care provider that aims to change the face of cancer care with modern treatments and techniques designed to achieve the best possible life outcomes for patients. In Australia, GenesisCare provides care to approximately 30,000 patients a year across 48 locations in metro and regional Victoria, New South Wales, Queensland, South Australia, and Western Australia.

GenesisCare是一家综合性癌症护理提供商，旨在通过现代治疗和技术改变癌症护理的面貌，旨在为患者实现尽可能最佳的生活结果。在澳大利亚，GenesisCare每年在维多利亚州、新南威尔士州、昆士兰、南澳大利亚州和西澳大利亚州的48个地点为大约30000名患者提供护理。

GenesisCare’s vision is to offer patients personalized, high-quality care throughout their cancer journey. For more information, visit www.genesiscare.com..

GenesisCare的愿景是在患者的整个癌症旅程中提供个性化，高质量的护理。有关更多信息，请访问www.genesiscare.com。。